Cargando…
Circulating Mesenchymal Stem Cells Microparticles in Patients with Cerebrovascular Disease
Preclinical and clinical studies have shown that the application of CD105(+) mesenchymal stem cells (MSCs) is feasible and may lead to recovery after stroke. In addition, circulating microparticles are reportedly functional in various disease conditions. We tested the levels of circulating CD105(+)...
Autores principales: | Kim, Suk Jae, Moon, Gyeong Joon, Cho, Yeon Hee, Kang, Ho Young, Hyung, Na Kyum, Kim, Donghee, Lee, Ji Hyun, Nam, Ji Yoon, Bang, Oh Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352849/ https://www.ncbi.nlm.nih.gov/pubmed/22615882 http://dx.doi.org/10.1371/journal.pone.0037036 |
Ejemplares similares
-
Antioxidant Effects of Statins in Patients with Atherosclerotic Cerebrovascular Disease
por: Moon, Gyeong Joon, et al.
Publicado: (2014) -
Automated in-depth cerebral arterial labelling using cerebrovascular vasculature reframing and deep neural networks
por: Hong, Suk-Woo, et al.
Publicado: (2023) -
Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells
por: Cha, Jae Min, et al.
Publicado: (2018) -
Serum-mediated Activation of Bone Marrow–derived Mesenchymal Stem Cells in
Ischemic Stroke Patients: A Novel Preconditioning Method
por: Moon, Gyeong Joon, et al.
Publicado: (2018) -
Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial
por: Kim, Suk Jae, et al.
Publicado: (2013)